Pathkey.AI Ltd (ASX:PKY)

Market Cap	47.26M +420.6%
Revenue (ttm)	47.63K +71.4%
Net Income	-3.65M
EPS	-0.01
Shares Out	1.35B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,090,557
Open	0.0390
Previous Close	0.0370
Day's Range	0.0350 - 0.0390
52-Week Range	0.0140 - 0.0750
Beta	1.48
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Pathkey.AI

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathke...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PKY

Financial Performance

In fiscal year 2026, Pathkey.AI's revenue was 47,632, an increase of 71.44% compared to the previous year's 27,783. Losses were -3.65 million, 152.3% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error